UNI NOVA – Research Magazine of the University of Basel
-
Alumni
An eye for risks and potential.
Interview: Bettina Volz / Is a newly marketed drug really safe? Epidemiologist Rahel Schneider identifies and quantifies the risks of drugs at Novartis in Basel. In addition, as a former scholarship holder, she is involved with the Swiss Study Foundation in screening young applicants.
-
Alumni
Networks support new start.
Text: Fabienne Gribi / Fabienne Gribi studierte in Basel Jurisprudenz und schloss 2012 ihre Anwaltsprüfung ab. Heute ist sie in New York als Unternehmensberaterin im Bereich Nachhaltigkeit und Innovation tätig.
-
Column
Dystopia as a mirror to society.
Text: Anna Karško / My book: literary scholar Anna Karško recommends two of her favorite books about futuristic dystopias.